Skip to main content

Table 4 Functional performance at M6, in remitted schizophrenic patients (RSWG-criteria)

From: Schizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study)

  Remitted patients Non-remitted patients p
Number of patients 374 (27.7 %) 976 (72.3 %)  
GAF total rating scorea 62.5 ± 1.5 48.3 ± 0.74 < 0.001
Social functioning
 Total rating scoreb 21.0 ± 0.19 17.2 ± 0.12 <0.001
 Social skills rating scoreb 12.8 ± 0.11 10.8 ± 0.07 <0.001
 Social roles rating scoreb 8.2 ± 0.10 6.4 ± 0.06 <0.001
  1. Values are given as mean ± SEM or as % of patients. M6, month 6 (end of study)
  2. aMaximum GAF rating score = 100
  3. bSocial functioning rating scores = total (from 7 to 28), social skills (from 4 to 16) and social roles (from 3 to 12)